SPL 1.03% 9.6¢ starpharma holdings limited

TGA interim decision re Astodrimer sodium nasal spray this week, page-6

  1. 3,309 Posts.
    lightbulb Created with Sketch. 779
    We are discussing DEP cancer drugs for pancreatic cancer. The 100% false statement is below:

    ‘We know that DEP has been effective in Pancreatic cancer Phase 3 trials so maybe DEP is assisting minimising adverse effects of chemotherapy’
    ~@starlink

    Even you couldn't justify this incorrect and misleading statement.
    Last edited by sarge17: 27/03/24
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.